Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-06

Clinical Trial Update: Assessing the Role of the NLRP3 Inflammasome in Intercritical Gout

View source ↗

Summary

A clinical trial update examining the role of the NLRP3 inflammasome in intercritical gout, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Attune Health Research, Inc. | Conditions: Gout | Status: ACTIVE_NOT_RECRUITING